Evidence map›Paper›PMID 28435454›Full record

ArticleTheranostics2017

Dual Somatostatin Receptor/FDG PET/CT Imaging in Metastatic Neuroendocrine Tumours: Proposal for a Novel Grading Scheme with Prognostic Significance.

David Lh Chan, Nick Pavlakis, Geoffrey P Schembri, Elizabeth J Bernard, Edward Hsiao, Aimee Hayes, Tristan Barnes, Connie Diakos, Mustafa Khasraw, Jaswinder Samra and 5 more

Open access · goldAbstract readEvaluation Study
PubMed Full text at PMC Publisher
In one paragraph

Article in Theranostics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 143 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
143citing papers in PubMed, 2 pooled it
11.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

143 citing papers in PubMed, 2 syntheses or guidelines pooled it, 279 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. A prospective head-to-head comparison ofEuropean journal of nuclear medicine and molecular imaging · 2022
    Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Clinical research analysis of [European journal of nuclear medicine and molecular imaging · 2026
    Article
  11. The prognostic effect of dualBMC gastroenterology · 2026
    Article
  12. Review
  13. Article
  14. Article
  15. PET in myeloma redefined: a comparative imaging study with FDG and fluorocholine PET/CT.European journal of nuclear medicine and molecular imaging · 2026
    Article
  16. Article
  17. Prognostic impact of discordant lesions on [Frontiers in nuclear medicine · 2026
    Article
  18. Review
  19. Article
  20. Review

83 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors at 2 institutions in 1 country.

David Lh ChanDepartments of Nuclear Medicine, Medical Oncology and Surgery, Royal North Shore Hospital, Sydney Medical School and Faculty of Health Sciences, University of Sydney, and Sydney Vital Translational Cancer Research Centre, Sydney, Australia.
Nick PavlakisDepartments of Nuclear Medicine, Medical Oncology and Surgery, Royal North Shore Hospital, Sydney Medical School and Faculty of Health Sciences, University of Sydney, and Sydney Vital Translational Cancer Research Centre, Sydney, Australia.
Geoffrey P SchembriDepartments of Nuclear Medicine, Medical Oncology and Surgery, Royal North Shore Hospital, Sydney Medical School and Faculty of Health Sciences, University of Sydney, and Sydney Vital Translational Cancer Research Centre, Sydney, Australia.
Elizabeth J BernardDepartments of Nuclear Medicine, Medical Oncology and Surgery, Royal North Shore Hospital, Sydney Medical School and Faculty of Health Sciences, University of Sydney, and Sydney Vital Translational Cancer Research Centre, Sydney, Australia.
Edward HsiaoDepartments of Nuclear Medicine, Medical Oncology and Surgery, Royal North Shore Hospital, Sydney Medical School and Faculty of Health Sciences, University of Sydney, and Sydney Vital Translational Cancer Research Centre, Sydney, Australia.
Aimee HayesDepartments of Nuclear Medicine, Medical Oncology and Surgery, Royal North Shore Hospital, Sydney Medical School and Faculty of Health Sciences, University of Sydney, and Sydney Vital Translational Cancer Research Centre, Sydney, Australia.
Tristan BarnesDepartments of Nuclear Medicine, Medical Oncology and Surgery, Royal North Shore Hospital, Sydney Medical School and Faculty of Health Sciences, University of Sydney, and Sydney Vital Translational Cancer Research Centre, Sydney, Australia.
Connie DiakosDepartments of Nuclear Medicine, Medical Oncology and Surgery, Royal North Shore Hospital, Sydney Medical School and Faculty of Health Sciences, University of Sydney, and Sydney Vital Translational Cancer Research Centre, Sydney, Australia.
Mustafa KhasrawDepartments of Nuclear Medicine, Medical Oncology and Surgery, Royal North Shore Hospital, Sydney Medical School and Faculty of Health Sciences, University of Sydney, and Sydney Vital Translational Cancer Research Centre, Sydney, Australia.
Jaswinder SamraDepartments of Nuclear Medicine, Medical Oncology and Surgery, Royal North Shore Hospital, Sydney Medical School and Faculty of Health Sciences, University of Sydney, and Sydney Vital Translational Cancer Research Centre, Sydney, Australia.
Enid EslickDepartments of Nuclear Medicine, Medical Oncology and Surgery, Royal North Shore Hospital, Sydney Medical School and Faculty of Health Sciences, University of Sydney, and Sydney Vital Translational Cancer Research Centre, Sydney, Australia.
Paul J RoachDepartments of Nuclear Medicine, Medical Oncology and Surgery, Royal North Shore Hospital, Sydney Medical School and Faculty of Health Sciences, University of Sydney, and Sydney Vital Translational Cancer Research Centre, Sydney, Australia.
Alexander EngelDepartments of Nuclear Medicine, Medical Oncology and Surgery, Royal North Shore Hospital, Sydney Medical School and Faculty of Health Sciences, University of Sydney, and Sydney Vital Translational Cancer Research Centre, Sydney, Australia.
Stephen J ClarkeDepartments of Nuclear Medicine, Medical Oncology and Surgery, Royal North Shore Hospital, Sydney Medical School and Faculty of Health Sciences, University of Sydney, and Sydney Vital Translational Cancer Research Centre, Sydney, Australia.
Dale L BaileyDepartments of Nuclear Medicine, Medical Oncology and Surgery, Royal North Shore Hospital, Sydney Medical School and Faculty of Health Sciences, University of Sydney, and Sydney Vital Translational Cancer Research Centre, Sydney, Australia.
Royal North Shore Hospital · AUUniversity of Sydney · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Fluorodeoxyglucose F18HumansNeoplasm GradingNeuroendocrine TumorsPositron Emission Tomography Computed TomographyPrognosisReceptors, SomatostatinRetrospective StudiesFluorodeoxyglucose F18Receptors, SomatostatinNeuroendocrine tumourPET scans

Identifiers

PMID28435454
PMCPMC5399582
OpenAlexW2592442081

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.